Curexo Inc. (KOSDAQ:060280)
South Korea · Delayed Price · Currency is KRW 15,230
-290 (-1.87%)
Mar 20, 2026, 3:30 PM KST
Curexo Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2015 | FY 2014 | FY 2013 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '15 Dec 31, 2015 | Dec '14 Dec 31, 2014 | Dec '13 Dec 31, 2013 |
Operating Revenue | 74,532 | 55,531 | 27,530 | 26,138 | 31,091 |
Other Revenue | -0 | -0 | 0 | 0 | - |
| 74,532 | 55,531 | 27,530 | 26,138 | 31,091 | |
Revenue Growth (YoY) | 34.22% | 101.72% | 5.33% | -15.93% | 28.05% |
Cost of Revenue | 49,709 | 40,913 | 25,125 | 22,775 | 27,188 |
Gross Profit | 24,823 | 14,618 | 2,404 | 3,363 | 3,903 |
Selling, General & Admin | 10,236 | 10,015 | 18,948 | 11,620 | 8,521 |
Research & Development | 10,428 | 9,467 | 7,559 | 11,929 | 7,858 |
Amortization of Goodwill & Intangibles | 33.81 | 34.62 | 324.43 | 83.17 | 89.32 |
Other Operating Expenses | 42.23 | 46.75 | 92.61 | 51.34 | 49.84 |
Operating Expenses | 22,461 | 20,440 | 27,163 | 24,096 | 17,944 |
Operating Income | 2,362 | -5,822 | -24,759 | -20,733 | -14,041 |
Interest Expense | -87.42 | -96.17 | -136.35 | -811.2 | -77.96 |
Interest & Investment Income | 930.39 | 1,499 | 76.68 | 94.7 | 80.62 |
Earnings From Equity Investments | - | - | - | - | -466.32 |
Currency Exchange Gain (Loss) | -150.56 | 1,450 | 18.25 | 42.15 | -23.92 |
Other Non Operating Income (Expenses) | -181.17 | -131.12 | -221.77 | -662.86 | -66.9 |
EBT Excluding Unusual Items | 2,873 | -3,100 | -25,022 | -22,070 | -14,595 |
Gain (Loss) on Sale of Investments | -42.25 | -5,569 | - | - | - |
Gain (Loss) on Sale of Assets | - | - | 6.18 | - | 1.1 |
Asset Writedown | - | - | - | -196.76 | - |
Pretax Income | 2,831 | -8,669 | -25,016 | -22,267 | -14,594 |
Income Tax Expense | 59.32 | 88.97 | 0.91 | 0.84 | 0.88 |
Earnings From Continuing Operations | 2,771 | -8,758 | -25,017 | -22,267 | -14,595 |
Net Income to Company | 2,771 | -8,758 | -25,017 | -22,267 | -14,595 |
Minority Interest in Earnings | - | - | 15,614 | 11,408 | 7,130 |
Net Income | 2,771 | -8,758 | -9,402 | -10,859 | -7,465 |
Net Income to Common | 2,771 | -8,758 | -9,402 | -10,859 | -7,465 |
Shares Outstanding (Basic) | 41 | 41 | 27 | 27 | 27 |
Shares Outstanding (Diluted) | 41 | 41 | 27 | 27 | 27 |
Shares Change (YoY) | 0.60% | 54.54% | -0.03% | 0.18% | 8.90% |
EPS (Basic) | 67.00 | -213.00 | -353.39 | -408.00 | -281.00 |
EPS (Diluted) | 67.00 | -213.00 | -353.39 | -408.00 | -281.00 |
Free Cash Flow | -13,742 | 465.3 | -22,843 | -22,141 | -15,396 |
Free Cash Flow Per Share | -332.21 | 11.32 | -858.56 | -831.90 | -579.53 |
Gross Margin | 33.31% | 26.32% | 8.73% | 12.87% | 12.55% |
Operating Margin | 3.17% | -10.48% | -89.94% | -79.32% | -45.16% |
Profit Margin | 3.72% | -15.77% | -34.15% | -41.55% | -24.01% |
Free Cash Flow Margin | -18.44% | 0.84% | -82.98% | -84.71% | -49.52% |
EBITDA | 5,147 | -3,655 | -22,851 | -19,451 | -13,249 |
EBITDA Margin | 6.91% | -6.58% | -83.01% | -74.42% | -42.61% |
D&A For EBITDA | 2,785 | 2,166 | 1,908 | 1,281 | 792.07 |
EBIT | 2,362 | -5,822 | -24,759 | -20,733 | -14,041 |
EBIT Margin | 3.17% | -10.48% | -89.94% | -79.32% | -45.16% |
Effective Tax Rate | 2.10% | - | - | - | - |
Advertising Expenses | 318.18 | 371.88 | 229.67 | 303.9 | 51.09 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.